InspireMD, Inc. NSPR
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -74.72%
- 1 year
- -79.45%
- Open
- 0.44
- Prev close
- 0.4514
- Mkt cap
- 20.92M
- Vol
- 478.66K
- Avg vol
- 131.80K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.44
- High
- 0.4729
- Forward P/E
- -4.15
- Beta
- 0.00
- Short ratio
- 2.26
- Inst. own
- 40.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.69
- 200-d avg
- 2.57
- 1y target
- 4.75
5D chart
Signals (169)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 1:30 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:25 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:25 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 1:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:00 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 12:45 PM | 2 days ago |
| RSI: Overbought | Oct 30, 12:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:20 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:20 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:25 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:25 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:25 PM | 2 days ago |
| RSI: Oversold | Oct 29, 3:25 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:30 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:05 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:30 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:10 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:00 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:45 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:35 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:40 AM | 6 days ago |
News
3 days ago globenewswire.com
InspireMD to Announce Third Quarter 2026 Financial Results
MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares increased by 27.9% to $2.79 during Friday's pre-market session. The company's market cap stands at $5.2 million. Picard Medical (AMEX:PMI) stock…
1 month ago globenewswire.com
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 -
-
1 month ago benzinga.com
Full Transcript: InspireMD Q2 2026 Earnings Call
InspireMD (NASDAQ:NSPR) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you…
1 month ago globenewswire.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today…
1 month ago globenewswire.com
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday's pre-market session. The company's market cap stands at $7.0 million. Aligos Therapeutics (NASDAQ:ALGS)…
2 months ago benzinga.com
Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Dell Technologies (DELL) stock jumps in pre-market trading after reporting better-than-expected Q2 results and raising FY27 guidance. Other gainers include UPC, GTLB, VIVK, UFG, MLEC, FFAI, GPUS,…
2 months ago zacks.com
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know
InspireMD (NSPR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2 months ago seekingalpha.com
InspireMD, Inc. (NSPR) Q2 2026 Earnings Call Transcript
InspireMD, Inc. (NSPR) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
InspireMD Q2 EPS $(0.17) Beats $(0.19) Estimate, Sales $1.771M Miss $2.133M Estimate
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 34.62 percent increase over losses of $(0.26)…
2 months ago globenewswire.com
InspireMD Reports Second Quarter 2026 Financial Results
- Company to host investor conference call today, August 17 th , at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of…
2 months ago zacks.com
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.26 per share a year ago.
2 months ago globenewswire.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today…
3 months ago globenewswire.com
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
Ms. Kennedy returns to InspireMD having previously served as Sales Director supporting the initial U.S. launch of CGuard Prime Ms. Kennedy returns to InspireMD having previously served as Sales…
4 months ago zacks.com
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
NSPR's positive CGUARDIANS II data show 100% acute device success, supporting a potential FDA approval for CGuard Prime TCAR in late 2026.
4 months ago globenewswire.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI, June 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today…
-
4 months ago benzinga.com
InspireMD Announces 30-Day Outcomes From CGUARDIANS II Clinical Trial Of CGuard Prime 80cm Implant For Use In Transcarotid Artery Revascularization Procedures
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced 30-day outcomes from the CGUARDIANS II…
4 months ago globenewswire.com
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
MIAMI, June 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
-
4 months ago benzinga.com
InspireMD Announces First Patient Enrolled In CGUARDIANS III Pivotal Study Of SwitchGuard Neuro Protection System, For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the first patient has been…
4 months ago globenewswire.com
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
5 months ago seekingalpha.com
InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
5 months ago globenewswire.com
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
MIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today…
-
5 months ago benzinga.com
Piper Sandler Reiterates Overweight on InspireMD, Lowers Price Target to $3
Piper Sandler analyst Adam Maeder reiterates InspireMD (NASDAQ:NSPR) with a Overweight and lowers the price target from $4 to $3.
6 months ago zacks.com
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
InspireMD, Inc. (NSPR) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.22 per share a year ago.
6 months ago seekingalpha.com
InspireMD, Inc. (NSPR) Q1 2026 Earnings Call Transcript
InspireMD, Inc. (NSPR) Q1 2026 Earnings Call Transcript
-
6 months ago benzinga.com
Transcript: InspireMD Q1 2026 Earnings Conference Call
Transcript: InspireMD Q1 2026 Earnings Conference Call
-
6 months ago benzinga.com
InspireMD Q1 EPS $(0.16) Beats $(0.19) Estimate, Sales $3.398M Beat $2.698M Estimate
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 27.27 percent increase over losses of $(0.22)…
6 months ago globenewswire.com
InspireMD Reports First Quarter 2026 Financial Results
- Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard neuro…
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
6 months ago benzinga.com
InspireMD Withdraws Prior Full Year 2026 Revenue Guidance; Says Given The Impact Of The Temporary Discontinuation Of Commercial Activity In The U.S. Pending The Anticipated FDA Approval Of Its Original CGuard Stent Delivery System In Q3 2026
2026 Financial GuidanceConcurrent with today's announcement, the Company is withdrawing its prior full year 2026 revenue guidance. Management believes this is the most prudent step given the impact…
-
6 months ago benzinga.com
InspireMD Initiates Voluntary U.S. Recall Of CGuard Prime 135cm Carotid Stent Delivery System; Recall Follows Technical Performance Of CGuard Prime 135cm Not Meeting Expectations; Recall Does Not Include CGuard Stent Implant; FDA Approval Of CGuard Prime 80cm For TCAR Anticipated In 2H 2026; FDA Approval, U.S. Availability Of Original CGuard Delivery System Anticipated In Q3 2026; Implementing Design Improvements To CGuard Prime Stent Delivery System
- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% - - FDA approval anticipated with U.S. market…
-
6 months ago benzinga.com
InspireMD Initiates Voluntary Recall For Its CGuard Prime 135 Cm Carotid Stent Delivery System
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD," or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that, in consultation with the U.S.…
-
6 months ago benzinga.com
InspireMD Says FDA Approves IDE Application To Initiate CGUARDIANS III Pivotal Study Of SwitchGuard NPS, Including Next Gen Enhancements From Prior IDE Approval For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the U.S. Food and Drug…
6 months ago globenewswire.com
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% -
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
7 months ago benzinga.com
Earnings Scheduled For March 18, 2026
Earnings Scheduled For March 18, 2026
-
7 months ago benzinga.com
InspireMD Q4 EPS $(0.14) Beats $(0.19) Estimate, Sales $3.149M Beat $2.626M Estimate
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 27.46 percent. This is a 26.32 percent increase over losses of $(0.19)…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
9 months ago benzinga.com
InspireMD Publishes Data From Its C-GUARDIANS Pivotal Study Journal Of The American College of Cardiology
InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that results from the Company's…
-
11 months ago benzinga.com
InspireMD CREST-2 Data Demonstrates Addition Of Stenting Improves Outcomes In Trial For Participants With Asymptomatic Carotid Stenosis
InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, welcomes the recent presentation and publication of…
12 months ago benzinga.com
Earnings Scheduled For November 4, 2025
Earnings Scheduled For November 4, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
1 year ago benzinga.com
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session